SCHEMBL4979173

SCHEMBL4979173

CCCNC(=O)N(S)c1ccc2c(c1)Cc1cc(Br)ccc1-2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
SLC1A3 P43003 1/20 0.38
SLC1A2 P43004 1/20 0.38
SLC1A1 P43005 1/20 0.38
RAB9A P51151 5/20 0.36
METAP1 P53582 1/20 0.36
NPC1 O15118 4/20 0.35
SRD5A1 P18405 1/20 0.35
SRD5A2 P31213 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.34
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
HSD17B10 Q99714 1/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 2/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4979942 0.93 MGLL (0.38) NAMPTSLC1A3SLC1A2SLC1A1RAB9A
SCHEMBL3982025 0.92 MGLL (0.42) NAMPTSLC1A3SLC1A2SLC1A1RAB9A
SCHEMBL4984400 0.92 MGLL (0.42) NAMPTSLC1A3SLC1A2SLC1A1RAB9A
SCHEMBL3977113 0.92 MGLL (0.42) NAMPTSLC1A3SLC1A2SLC1A1RAB9A
SCHEMBL4979475 0.92 MGLL (0.42) NAMPTSLC1A3SLC1A2SLC1A1RAB9A
SCHEMBL4980233 0.90 SLC1A3 (0.40) NAMPTSLC1A3SLC1A2SLC1A1RAB9A
SCHEMBL4983200 0.89 LMNA (0.43) L3MBTL1SLC1A3SLC1A2SLC1A1SMN1; SMN2
SCHEMBL4979553 0.88 CYP1A2 (0.44) SLC1A3SLC1A2SLC1A1METAP1SRD5A1
SCHEMBL4980970 0.86 KDM4E (0.46) L3MBTL1SLC1A3SLC1A2SLC1A1METAP1
SCHEMBL4980961 0.85 LMNA (0.42) SLC1A3SLC1A2SLC1A1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080096875-A1 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096875-A1 THIOUREA COMPOUNDS TPMT, HAVCR2, ETV6 NAMPT 2150/4885L3MBTL1 822/4885SLC1A3 1879/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.